Interventions for chronic kidney disease in people with sickle cell disease.
This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness of any intervention in preventing or reducing kidney complications or CKD in people with SCD (including red blood cell transfusions, hydroxyurea and ACEI (either alone or in combination with each other)).
Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Noemi Ba
NB
Roy
Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK.
Patricia M
PM
Fortin
Oxford Kidney Unit and Nuffield Department of Medicine, Oxford University Hospitals Trust and the University of Oxford, Oxford, UK.
Katherine R
KR
Bull
Systematic Review Initiative, NHS Blood and Transplant, Oxford, UK.
Carolyn
C
Doree
Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
Marialena
M
Trivella
Oxford Clinical Trials Research Unit, University of Oxford, Oxford, UK.
Sally
S
Hopewell
Haematology/Transfusion Medicine, NHS Blood and Transplant, Oxford, UK.
Lise J
LJ
Estcourt